Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ELVN-001 |
Trade Name | |
Synonyms | ELVN 001|ELVN001 |
Drug Descriptions |
ELVN-001 is an ATP-competitive tyrosine kinase inhibitor with selective activity against ABL1, which potentially leads to decreased tumor cell proliferation and antitumor activity (Blood (2022) 140 (Supplement 1): 3095-3096). |
DrugClasses | ABL1 Inhibitor 8 |
CAS Registry Number | NA |
NCIT ID | C190745 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ELVN-001 | ELVN-001 | 0 | 1 |